DDX53 and neoplasm: The obtained results of L-boronphenylalanine biodistribution dynamics demonstrate the tumor model (subcutaneous xenograft of CT26 in BALB/c mice) feasibility to assess the efficiency of new neutron sources for boron neutron capture therapy.